VistaGen Therapeutics, Inc.
Hedge Funds Holdings
Last updated:
VistaGen Therapeutics, Inc.‘s stocks are currently a part of 62 hedge funds’ portfolios, which represents 100% of the total amount of its stocks outstanding. This makes up a total of 19.96M shares of VistaGen Therapeutics, Inc.. Compared to the previous quarter, the number fell by -51.11% or -20.87M shares fewer. As for the holding position changes, 27.42% (17) of current hedge fund investors increased the number of shares held, 20.97% (13) of current holders sold a part of the shares held, and 12.9% (8) closed the holdings completely. 8 hedge funds are new holders of VistaGen Therapeutics, Inc. stock in Q1 2023, it is 12.9% of total holders.
Hedge funds holding VistaGen Therapeutics (Q2 2018 – Q1 2023)
| Q2 2018 | 20 |
|---|---|
| Q3 2018 | 16 |
| Q4 2018 | 20 |
| Q1 2019 | 25 |
| Q2 2019 | 21 |
| Q3 2019 | 23 |
| Q4 2019 | 24 |
| Q1 2020 | 19 |
| Q2 2020 | 23 |
| Q3 2020 | 26 |
| Q4 2020 | 51 |
| Q1 2021 | 73 |
| Q2 2021 | 99 |
| Q3 2021 | 101 |
| Q4 2021 | 104 |
| Q1 2022 | 113 |
| Q2 2022 | 108 |
| Q3 2022 | 86 |
| Q4 2022 | 84 |
| Q1 2023 | 62 |
Hedge funds changes in VistaGen Therapeutics positions (Q2 2018 – Q1 2023)
| Q2 2018 | 7 | 6 | 1 | 4 | 2 |
|---|---|---|---|---|---|
| Q3 2018 | 2 | 3 | 2 | 6 | 3 |
| Q4 2018 | 5 | 6 | 2 | 1 | 6 |
| Q1 2019 | 11 | 4 | 1 | 6 | 3 |
| Q2 2019 | 3 | 4 | 2 | 7 | 5 |
| Q3 2019 | 5 | 5 | 1 | 3 | 9 |
| Q4 2019 | 4 | 2 | 6 | 3 | 9 |
| Q1 2020 | 1 | 7 | 0 | 4 | 7 |
| Q2 2020 | 5 | 2 | 2 | 2 | 12 |
| Q3 2020 | 5 | 6 | 2 | 2 | 11 |
| Q4 2020 | 29 | 8 | 3 | 4 | 7 |
| Q1 2021 | 32 | 28 | 5 | 10 | -2 |
| Q2 2021 | 45 | 23 | 22 | 19 | -10 |
| Q3 2021 | 17 | 34 | 29 | 12 | 9 |
| Q4 2021 | 13 | 38 | 29 | 11 | 13 |
| Q1 2022 | 19 | 29 | 38 | 11 | 16 |
| Q2 2022 | 20 | 31 | 36 | 22 | -1 |
| Q3 2022 | 17 | 29 | 26 | 39 | -25 |
| Q4 2022 | 13 | 23 | 23 | 16 | 9 |
| Q1 2023 | 8 | 17 | 13 | 8 | 16 |
Hedge funds changes in VistaGen Therapeutics stock options (Q2 2018 – Q1 2023)
| Q2 2018 | 0 | 0 |
|---|---|---|
| Q3 2018 | 0 | 0 |
| Q4 2018 | 0 | 0 |
| Q1 2019 | 0 | 0 |
| Q2 2019 | 0 | 0 |
| Q3 2019 | 0 | 0 |
| Q4 2019 | 0 | 0 |
| Q1 2020 | 0 | 0 |
| Q2 2020 | 0 | 0 |
| Q3 2020 | 0 | 0 |
| Q4 2020 | 0 | 0 |
| Q1 2021 | 0 | 0 |
| Q2 2021 | 0 | 0 |
| Q3 2021 | 50,000 | 704,000 |
| Q4 2021 | 73,000 | 1,039,000 |
| Q1 2022 | 41,000 | 487,000 |
| Q2 2022 | 2,474,000 | 1,406,000 |
| Q3 2022 | 422,000 | 19,000 |
| Q4 2022 | 3,688 | 1,525 |
| Q1 2023 | 0 | 0 |